一分钟看懂
这是一项关于非小细胞肺癌的II 期 / III 期研究，登记的药物或干预包括Adagrasib；Pembrolizumab，当前状态为招募中。登记地点显示中国蚌埠、合肥、北京、重庆等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
Adagrasib；Pembrolizumab · II 期 / III 期
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- Local Institution - 007-051 · 蚌埠
- The First Affiliated Hospital of Bengbu Medical College/Department of Respiratory and Critical Care Medicine · 蚌埠
- Anhui Provincial Hospital · 合肥
- Local Institution - 007-026-Ph2 · 合肥
- Local Institution - 007-026 · 合肥
- Local Institution - 007-739-Ph2 · 合肥
- Local Institution - 007-739 · 合肥
- Local Institution - 007-747 · 合肥
- Cancer Hospital Chinese Academy of Medical Sciences/Medical Oncology Department · 北京
- Local Institution - 007-050 · 北京
- Local Institution - 007-707-Ph2 · 北京
- Local Institution - 007-707 · 北京
- Local Institution - 1025-Ph2 · 北京
- Local Institution - 1025 · 北京
- Beijing Cancer Hospital/Thoracic Oncology(2nd) Department · 北京
- Beijing Cancer hospital · 北京
- Local Institution - 007-027-Ph2 · 北京
- Local Institution - 007-038-Ph2 · 北京
- Local Institution - 007-038 · 北京
- Local Institution - 007-040-Ph2 · 北京
- Local Institution - 007-040 · 北京
- Local Institution - 007-718-Ph3 · 重庆
- Local Institution - 1029-Ph2 · 重庆
- Local Institution - 1029 · 重庆
- Chongqing University Three Gorges Hospital/Respiratory Ward of Tumor Center · 重庆
- Local Institution - 007-053 · 重庆
- Local Institution - 1046-Ph2 · 福州
- Local Institution - 1046 · 福州
- Fujian Cancer Hospital · 福州
- Local Institution - 007-039-Ph2 · 福州
- Local Institution - 007-039 · 福州
- Local Institution - 007-714-Ph2 · 厦门
- Local Institution - 007-714 · 厦门
- Local Institution - 007-732-Ph2 · 厦门
- Local Institution - 007-732 · 厦门
- The First Affiliated Hospital of Xiamen University/Medical Oncology Department · 厦门
- Local Institution - 1022-Ph2 · 广州
- Local Institution - 1022 · 广州
- Local Institution - 007-712-Ph2 · 广州
- Local Institution - 007-712 · 广州
- The First Affiliated Hospital of Guangzhou Medical University · 广州
- Local Institution - 007-705-Ph2 · 广州
- Local Institution - 007-705 · 广州
- Nanfang Hospital, Southern Medical University/Respiratory Medicine Department · 广州
- Local Institution - 007-052 · 深圳
- Shenzhen People's Hospital/Department of Respiratory and Critical Care Medicine · 深圳
- Local Institution - 007-704-Ph2 · 柳州
- Local Institution - 007-704 · 柳州
- Guangxi Medical University Cancer Hospital/Department of Respiratory Oncology · 南宁
- Local Institution - 007-384 · 南宁
- Local Institution - 007-744-Ph2 · 南宁
- Local Institution - 1038-Ph2 · 南宁
- Local Institution - 1038 · 南宁
- Local Institution - 007-742 · 石家庄
- The Fourth Hospital of Hebei Medical University · 石家庄
- Local Institution - 007-028 · 哈尔滨
- Cancer Hospital affiliated to Harbin Medical University/Ward 3 of Respiratory Medicine Department · 哈尔滨
- Local Institution - 007-028-Ph2 · 哈尔滨
- Local Institution - 1012-Ph2 · 新乡
- Henan Cancer Hospital/Second Ward of Respiratory Medicine Department · 郑州
- Local Institution - 007-730-Ph3 · 郑州
- Local Institution - 1010-Ph2 · 郑州
- Local Institution - 1010 · 郑州
- Local Institution - 007-021-Ph2 · 郑州
- Local Institution - 007-715-Ph2 · 郑州
- Local Institution - 007-715 · 郑州
- Local Institution - 007-730-Ph2 · 郑州
- Local Institution - 007-719-Ph2 · 武汉
- Union Hospital Affiliated with Tongji Medical College of Huazhong University of Science and Technology/Cancer Center Department · 武汉
- Local Institution - 007-700-Ph2 · 武汉
- Local Institution - 007-700 · 武汉
- Local Institution - 007-701-Ph2 · 长沙
- Hunan Cancer Hospital/Thoracic Medicine Department II · 长沙
- Local Institution - 1021-Ph2 · 南京
- Local Institution - 1021 · 南京
- Nanjing First Hospital/Department of Respiratory and Critical Care Medicine · 南京
- Nanjing First Hospital/Respiratory Department · 南京
- Local Institution - 1018-Ph2 · 南京
- Local Institution - 1018 · 南京
- Local Institution - 1020-Ph2 · 南京
- Local Institution - 1020 · 南京
- Local Institution - 1004-Ph2 · 南通
- Local Institution - 1004 · 南通
- Local Institution - 1017-Ph2 · 徐州
- Local Institution - 1017 · 徐州
- Local Institution - 007-713-Ph2 · 南昌
- Local Institution - 1040-Ph2 · 南昌
- Local Institution - 1040 · 南昌
- The First Affiliated Hospital of Nanchang University · 南昌
- Local Institution - 1006-Ph2 · 长春
- Local Institution - 1006 · 长春
- Local Institution - 007-717-Ph2 · 长春
- The First Bethune Hospital Of Jilin University/Oncology Department · 长春
- Local Institution - 007-741-Ph2 · 沈阳
- Local Institution - 007-741 · 沈阳
- Local Institution - 1008-Ph2 · 沈阳
- Local Institution - 1008 · 沈阳
- Local Institution - 007-749 · 沈阳
- Shengjing Hospital of China Medical University · 沈阳
- Local Institution - 007-702-Ph2 · 沈阳
- Local Institution - 007-702 · 沈阳
- Local Institution - 007-746-Ph3 · 银川
- Local Institution - 007-746 · 银川
- Local Institution - 007-718-Ph2 · 西安
- Local Institution - 007-721-Ph2 · 西安
- Local Institution - 007-721 · 西安
- The First Affiliated Hospital of Xi'an Jiaotong University/Medical Oncology Department · 西安
- Local Institution - 007-708-Ph2 · 济南
- Shandong Cancer Hospital · 济南
- Local Institution - 007-737-Ph2 · 临沂
- Linyi Cancer Hospital/Oncology Department · 临沂
- Local Institution - 007-703-Ph2 · 临沂
- Local Institution - 007-703 · 临沂
- Local Institution - 007-709-Ph2 · 上海
- Local Institution - 007-709 · 上海
- Shanghai Chest Hospital-Oncology department · 上海
- Fudan University Shanghai Cancer Center/Thoracic Oncology Department · 上海
- Local Institution - 007-024-Ph2 · 上海
- Local Institution - 007-024-Ph3 · 上海
- Local Institution - 007-024 · 上海
- Local Institution - 007-035-Ph2 · 上海
- Local Institution - 007-740-Ph2 · 太原
- Local Institution - 007-740 · 太原
- Local Institution - 007-748 · 太原
- Shanxi Provincial Cancer Hospital/Respiratory Medicine · 太原
- Local Institution - 007-710-Ph2 · 成都
- Local Institution - 007-710 · 成都
- Local Institution - 007-720-Ph2 · 成都
- Sichuan Cancer hospital · 成都
- West China Hospital of Sichuan University · 成都
- Local Institution - 007-711-Ph2 · 泸州
- Local Institution - 007-711 · 泸州
- Local Institution - 007-743-Ph3 · 乌鲁木齐
- Local Institution - 007-743 · 乌鲁木齐
- Local Institution - 1036-Ph2 · 乌鲁木齐
- Local Institution - 1036 · 乌鲁木齐
- Local Institution - 1032-Ph2 · 昆明
- Local Institution - 1032 · 昆明
- Local Institution - 007-385-Ph3 · 昆明
- Local Institution - 007-385 · 昆明
- Local Institution - 007-745-Ph2 · 昆明
- Local Institution - 007-745 · 昆明
- Local Institution - 007-716-Ph2 · 杭州
- Local Institution - 007-716 · 杭州
- The First Affiliated Hospital, Zhejiang University School of Medicine · 杭州
- Local Institution - 007-036-Ph2 · 杭州
- Local Institution - 007-036 · 杭州
- Local Institution - 007-037-Ph2 · 杭州
- Zhejiang Cancer Hospital · 杭州
- Local Institution - 1050-Ph2 · 台州
- Local Institution - 1050 · 台州
- Taizhou Hospital Of Zhejiang Province · 台州
- Local Institution - 1043-Ph2 · 青岛
- Local Institution - 1043 · 青岛
- Local Institution - 007-035 · 上海
公开的入选条件
- * Phase 2: Histologically confirmed diagnosis of unresectable or metastatic NSCLC with KRAS G12C mutation and any PD-L1 TPS
- * Phase 3: Histologically confirmed diagnosis of unresectable or metastatic squamous or nonsquamous NSCLC with KRAS G12C mutation and PD-L1 TPS\>=50%
- * Phase 3: Presence of measurable disease per RECIST1.1
- * Phase 3: CNS Inclusion
- Based on screening brain imaging, patients must have one of the following:
- 1. No evidence of brain metastases
- 2. Untreated brain metastases not needing immediate local therapy
- 3. Previously treated brain metastases not needing immediate local therapy
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT04613596；登记信息更新于 2026-09-16。